LLY compared with AYTU: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

AYTUAytu Biopharma, Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

AYTUAytu Biopharma, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AYTU: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only AYTU 7

—Halo Pharmaceuticalunlistedsupplier

—Mission Pharmacalunlistedsupplier

—Tris Pharmaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Fabre-Kramerunlistedsupplier

3 more · AYTU chain ›

Price

rebased to 0%

LLY, solidAYTU, dashed

LLYELI Lilly & Co

1,360.86▼−0.28%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

AYTUAytu Biopharma, Inc

1.77▼−2.21%

Regular sessionNov 6 '26

Mkt cap$19.7MRevenue$16MQ4 FY26Revenue$58MFY26

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

AYTUAytu Biopharma, Inc

1,360.86▼−0.28%

Price

1.77▼−2.21%

$1.2T

Mkt cap

$19.7M

Q3 FY26$24.4B

Revenue

$16MQ4 FY26

FY25$65.2B

Revenue

$58MFY26

LLY1,360.86▼−0.28%vsAYTU1.77▼−2.21%Regular sessionNov 6 '26